Log in and
Username or Email
Forgot password?
Join and
You're almost done! Define a user name and password.
» Tip Us Hey you, we are hiring! Join us if you are an author, developer or designer!

FitBit teams up with DexCom for diabetes tracking wearable

08 September 2017 3

Fitbit Inc shares have rallied after the company announced a partnership with glucose-monitoring device company DexCom Inc. to allow diabetics to monitor their blood sugar through Fitbit’s new smartwatch.

Fitbit's shares were up 10% after the announcement. The prices were the highest for the company since January 2017, when the company laid off 6% of its staff and announced plans to make a smartwatch.

Fitbit stated that the collaboration would allow it and Dexcom “to develop and market products to help people better manage their diabetes and get a complete picture of their overall health with easy-to-use mobile tools.”

"With Ionic, we are focused on driving positive health outcomes and more health focused tools, and this collaboration is a wonderful example of how we plan to bring that vision to our users," said Fitbit CEO James Park in a statement.

“While we see this as an interesting strategic relationship that could help uptake in 2018, the key to the stock will be market acceptance of the Ionic amidst a crowded competitive field this holiday season,” said Stifel analyst Jim Duffy in a note Thursday. Duffy has put a “hold” rating on Fitbit with a target price of $6.

Nearly 400 million people around the globe suffer from diabetes, according to the World Heath Organization. Fitbit wearables with the new glucose monitoring feature would offer a painless method for users to check glucose levels.



Join our community » FitBit teams up with DexCom for diabetes tracking wearable

Best 10 irresistible gaming smartphones for every budget | June 2018


Best smartphones for music lovers | June 2018


Asus ROG gaming phone with Snapdragon 845 SoC, 90Hz AMOLED display launched


Xiaomi Mi Band 3 with OLED display and NFC support launched